Tevogen Bio amends Bylaws to modify director resignation procedure for majority vote failures

Tevogen Bio Holdings Inc.

Board amended Bylaws on April 21, 2025 to alter process for director resignations when director fails to receive majority vote in uncontested election.
Amendment filed as Exhibit 3.1; no other changes to Bylaws or fiscal year announced.
Procedural governance amendment with no immediate financial or operational impact.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.